CHIEF COMPLAINT: C/o Loss of vision in both eyes due to MDR TB since 2022. C/o blurred vision with light sensitivity in right eye and left eye with no vision. Loss of vision is associated with anti-TB drug toxicity. She has only hand movements’ vision in both eyes. Her side vision in both eyes is good, but central vision is absent. She has developed Nystagmus and squint in both eyes.

PRESENTING ILLNESS: An 18 years old female presented with history dimness of

vision since 2022 medicinal treatment is going on. She was diagnosed as MDR TB in 2022 and it was managed by conventional line of treatment under hospitalization. Later in 2023, MDR TB report came negative, after completion of her MDR TB Rx protocol of 20 months at KGMU, Lucknow. Dimness in both the eyes started progressing and went for Ophthalmologist for the same complaints. Now Patient along with her parents has come for getting her ONA treatment by experimental stem cell therapy. She and her parents has been explained about status of stem cell therapy in India about its experimental nature & they all have agreed voluntarily to undergo this experimental stem cell therapy. Written informed consent was taken and the same has been explained in their understandable language by treating stem cell therapy consultant and ophthalmologist

Fill out our treatment application form. The form is designed to help us understand your treatment goals.

Click on the Icons to See the Various Steps of Our Patient Treatment Process

@ 2025 Global Stem Cell Care. All rights reserved.

DISCLAIMER: As with any medical treatment, no guarantees or claim of cures are made as to the extent of the response to treatment. Results vary from patient to patient, even with a similar diagnosis, as the body’s internal status is unique to each individual patient. Because of this fact we cannot offer, infer or suggest that there is any certainty of a given outcome. Our treatments are not currently FDA approved. We do not use embryonic or fetal cells in any of our treatments.